Deep Health AI India seeks approval for two independent director appointments

1 min read     Updated on 03 Jul 2026, 08:10 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Deep Health AI India Ltd has announced an Extraordinary General Meeting (EGM) on July 30, 2026, to seek shareholder approval for the appointment of two independent directors, Mr. Bhupesh Swami and Mrs. Shashi Kala Dhabriya. The meeting will be conducted through video conferencing, with remote e-voting available from July 27 to July 29, 2026. The cut-off date to determine shareholder eligibility is July 23, 2026.

powered bylight_fuzz_icon
44559392

*this image is generated using AI for illustrative purposes only.

Deep Health AI India Ltd has scheduled an Extraordinary General Meeting (EGM) on July 30, 2026, to seek shareholder approval for the appointment of two independent directors. The meeting will be held via video conferencing at 3:00 PM IST. Shareholders can participate and vote through remote e-voting, which commences at 9:00 AM on July 27, 2026, and concludes at 5:00 PM on July 29, 2026. The cut-off date for determining eligibility is July 23, 2026.

The board approved the draft notice for the EGM during a meeting held on July 02, 2026. The regulatory filing was submitted to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements), 2015. The company, formerly known as Deep Diamond India Limited, is headquartered at 506-509 fifth floor, Apeksha, Plot No. 256, Main Road, Hiran Magri, Sector 11, Udaipur. The filing was signed by Managing Director Narayan Singh Rathore.

Proposed Appointments

The special business includes the appointment of Mr. Bhupesh Swami (DIN: 07999261) and Mrs. Shashi Kala Dhabriya (DIN: 11611776) as Non-Executive Independent Directors. Mr. Bhupesh Swami was appointed as an Additional Director w.e.f. July 02, 2026, and his tenure, if approved, will be for two consecutive years from July 02, 2026 to July 01, 2028. Mrs. Shashi Kala Dhabriya was appointed as an Additional Director w.e.f. March 20, 2026, and her tenure, if approved, will be for five consecutive years from March 20, 2026 to March 19, 2031.

Meeting Details

Event Date Time Venue
Board Meeting July 02, 2026 05:30 PM - 08:25 PM Video Conferencing
Extraordinary General Meeting July 30, 2026 03:00 PM Video Conferencing
Remote E-Voting Start July 27, 2026 09:00 AM NSDL E-Voting System
Remote E-Voting End July 29, 2026 05:00 PM NSDL E-Voting System

Members wishing to ask questions during the EGM must register as a speaker by sending a request from their registered email address to deephealthaiindia@gmail.com by July 23, 2026, at 5:00 PM IST. Mr. Ronak Jhuthawat, Sole Proprietor of M/s. Ronak Jhuthawat & Co, has been appointed as the Scrutinizer for the remote e-voting process.

Historical Stock Returns for Deep Health AI

1 Day5 Days1 Month6 Months1 Year5 Years
-0.46%0.0%-2.27%-66.77%-48.19%+106.73%

What strategic expertise will the new independent directors bring to support Deep Health AI's expansion in the healthcare technology sector?

How will the staggered tenure terms of the new directors influence the company's long-term governance stability and succession planning?

Does the appointment of these independent directors signal a shift in the company's business strategy following its rebranding from Deep Diamond India Limited?

Deep Health AI appoints Bhupesh Swami as independent director

0 min read     Updated on 02 Jul 2026, 06:46 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Deep Health AI India Ltd appointed Bhupesh Swami as an Additional Non-Executive Independent Director for a two-year term from July 02, 2026, to July 01, 2028. The board approved the appointment via circular resolution. Swami holds an MIB in Export-Import from CMS, Udaipur, and has no familial relationships with other directors.

powered bylight_fuzz_icon
44543794

*this image is generated using AI for illustrative purposes only.

deep health ai has appointed Bhupesh Swami as an Additional Non-Executive Independent Director on its board, effective July 02, 2026. The appointment was approved by the Board of Directors through a circular resolution on the same day. Swami will serve a two-year term, ending on July 01, 2028.

The disclosure was made to BSE Limited in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that Swami is not related to any other directors on the board.

Swami holds a Master India Boards (MIB) specialization in Export-Import, which he completed in 2016 from CMS, Udaipur. The appointment is part of the company's board governance structure.

Appointment Details

Particular Description
Name of Director Mr. Bhupesh Swami
DIN 07999261
Designation Additional Non-Executive Independent Director
Date of Appointment July 02, 2026
Term of Appointment Two years (July 02, 2026 to July 01, 2028)

Historical Stock Returns for Deep Health AI

1 Day5 Days1 Month6 Months1 Year5 Years
-0.46%0.0%-2.27%-66.77%-48.19%+106.73%

How will Bhupesh Swami's expertise in export-import influence Deep Health AI's strategic direction?

What specific governance improvements does the company expect from this board expansion?

Will Deep Health AI announce further board appointments to strengthen its leadership team?

More News on Deep Health AI

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-48.19%